Global HER2 Targeted Therapy Market Growth (Status and Outlook) 2021-2027
According to this latest study, the 2021 growth of HER2 Targeted Therapy will have significant change from previous year. By the most conservative estimates of global HER2 Targeted Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the HER2 Targeted Therapy market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2027.
This report presents a comprehensive overview, market shares, and growth opportunities of HER2 Targeted Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2027 in section 10.7.
Monotherapy
Combination Therapy
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2027 in section 10.8.
Breast Cancer
Stomach Cancer
Head and Neck Cancer
Lung Cancer
Ovarian Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Bayer
Abbott
AbbVie
Pfizer
Sanofi
Agilent
Glenmark Pharmaceuticals
Merck
Roche
Novartis
Astra Zeneca
Daiichi Sankyo
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global HER2 Targeted Therapy Market Size 2016-2026
2.1.2 HER2 Targeted Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 HER2 Targeted Therapy Segment by Type
2.2.1 Monotherapy
2.2.2 Monotherapy
2.2.3 Others
2.3 HER2 Targeted Therapy Market Size by Type
2.3.1 Global HER2 Targeted Therapy Market Size CAGR by Type
2.3.2 Global HER2 Targeted Therapy Market Size Market Share by Type (2016-2021)
2.4 HER2 Targeted Therapy Segment by Application
2.4.1 Breast Cancer
2.4.2 Stomach Cancer
2.4.3 Head and Neck Cancer
2.4.4 Lung Cancer
2.4.5 Ovarian Cancer
2.4.6 Others
2.5 HER2 Targeted Therapy Market Size by Application
2.5.1 Global HER2 Targeted Therapy Market Size CAGR by Application
2.5.2 Global HER2 Targeted Therapy Market Size Market Share by Application (2016-2021)
3 HER2 Targeted Therapy Market Size by Players
3.1 HER2 Targeted Therapy Market Size Market Share by Players
3.1.1 Global HER2 Targeted Therapy Revenue by Players (2019-2021E)
3.1.2 Global HER2 Targeted Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global HER2 Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HER2 Targeted Therapy by Regions
4.1 HER2 Targeted Therapy Market Size by Regions (2016-2021)
4.2 Americas HER2 Targeted Therapy Market Size Growth (2016-2021)
4.3 APAC HER2 Targeted Therapy Market Size Growth (2016-2021)
4.4 Europe HER2 Targeted Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa HER2 Targeted Therapy Market Size Growth (2016-2021)
5 Americas
5.1 Americas HER2 Targeted Therapy Market Size by Country (2016-2021)
5.2 Americas HER2 Targeted Therapy Market Size by Type (2016-2021)
5.3 Americas HER2 Targeted Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 Targeted Therapy Market Size by Region (2016-2021)
6.2 APAC HER2 Targeted Therapy Market Size by Type (2016-2021)
6.3 APAC HER2 Targeted Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe HER2 Targeted Therapy by Country (2016-2021)
7.2 Europe HER2 Targeted Therapy Market Size by Type (2016-2021)
7.3 Europe HER2 Targeted Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa HER2 Targeted Therapy by Region (2016-2021)
8.2 Middle East & Africa HER2 Targeted Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa HER2 Targeted Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global HER2 Targeted Therapy Market Forecast
10.1 Global HER2 Targeted Therapy Forecast by Regions (2021-2026)
10.1.1 Global HER2 Targeted Therapy Forecast by Regions (2021-2026)
10.1.2 Americas HER2 Targeted Therapy Forecast
10.1.3 APAC HER2 Targeted Therapy Forecast
10.1.4 Europe HER2 Targeted Therapy Forecast
10.1.5 Middle East & Africa HER2 Targeted Therapy Forecast
10.2 Americas HER2 Targeted Therapy Forecast by Countries (2021-2026)
10.2.1 United States HER2 Targeted Therapy Market Forecast
10.2.2 Canada HER2 Targeted Therapy Market Forecast
10.2.3 Mexico HER2 Targeted Therapy Market Forecast
10.2.4 Brazil HER2 Targeted Therapy Market Forecast
10.3 APAC HER2 Targeted Therapy Forecast by Region (2021-2026)
10.3.1 China HER2 Targeted Therapy Market Forecast
10.3.2 Japan HER2 Targeted Therapy Market Forecast
10.3.3 Korea HER2 Targeted Therapy Market Forecast
10.3.4 Southeast Asia HER2 Targeted Therapy Market Forecast
10.3.5 India HER2 Targeted Therapy Market Forecast
10.3.6 Australia HER2 Targeted Therapy Market Forecast
10.4 Europe HER2 Targeted Therapy Forecast by Country (2021-2026)
10.4.1 Germany HER2 Targeted Therapy Market Forecast
10.4.2 France HER2 Targeted Therapy Market Forecast
10.4.3 UK HER2 Targeted Therapy Market Forecast
10.4.4 Italy HER2 Targeted Therapy Market Forecast
10.4.5 Russia HER2 Targeted Therapy Market Forecast
10.5 Middle East & Africa HER2 Targeted Therapy Forecast by Region (2021-2026)
10.5.1 Egypt HER2 Targeted Therapy Market Forecast
10.5.2 South Africa HER2 Targeted Therapy Market Forecast
10.5.3 Israel HER2 Targeted Therapy Market Forecast
10.5.4 Turkey HER2 Targeted Therapy Market Forecast
10.5.5 GCC Countries HER2 Targeted Therapy Market Forecast
10.6 Global HER2 Targeted Therapy Forecast by Type (2021-2026)
10.7 Global HER2 Targeted Therapy Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline HER2 Targeted Therapy Product Offered
11.1.3 GlaxoSmithKline HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer HER2 Targeted Therapy Product Offered
11.2.3 Bayer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott HER2 Targeted Therapy Product Offered
11.3.3 Abbott HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie HER2 Targeted Therapy Product Offered
11.4.3 AbbVie HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer HER2 Targeted Therapy Product Offered
11.5.3 Pfizer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi HER2 Targeted Therapy Product Offered
11.6.3 Sanofi HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Agilent
11.7.1 Agilent Company Information
11.7.2 Agilent HER2 Targeted Therapy Product Offered
11.7.3 Agilent HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Agilent Main Business Overview
11.7.5 Agilent Latest Developments
11.8 Glenmark Pharmaceuticals
11.8.1 Glenmark Pharmaceuticals Company Information
11.8.2 Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered
11.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Glenmark Pharmaceuticals Main Business Overview
11.8.5 Glenmark Pharmaceuticals Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck HER2 Targeted Therapy Product Offered
11.9.3 Merck HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche HER2 Targeted Therapy Product Offered
11.10.3 Roche HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11. Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis HER2 Targeted Therapy Product Offered
11.11.3 Novartis HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 Astra Zeneca
11.12.1 Astra Zeneca Company Information
11.12.2 Astra Zeneca HER2 Targeted Therapy Product Offered
11.12.3 Astra Zeneca HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Astra Zeneca Main Business Overview
11.12.5 Astra Zeneca Latest Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Information
11.13.2 Daiichi Sankyo HER2 Targeted Therapy Product Offered
11.13.3 Daiichi Sankyo HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Daiichi Sankyo Main Business Overview
11.13.5 Daiichi Sankyo Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. HER2 Targeted Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Monotherapy
Table 3. Major Players of Combination Therapy
Table 4. Major Players of Others
Table 5. HER2 Targeted Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global HER2 Targeted Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global HER2 Targeted Therapy Market Size Market Share by Type (2016-2021)
Table 8. HER2 Targeted Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global HER2 Targeted Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global HER2 Targeted Therapy Market Size Market Share by Application (2016-2021)
Table 11. Global HER2 Targeted Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global HER2 Targeted Therapy Revenue Market Share by Players (2019-2021E)
Table 13. HER2 Targeted Therapy Key Players Head office and Products Offered
Table 14. HER2 Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global HER2 Targeted Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global HER2 Targeted Therapy Market Size Market Share by Regions 2016-2021
Table 19. Americas HER2 Targeted Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas HER2 Targeted Therapy Market Size Market Share by Country (2016-2021)
Table 21. Americas HER2 Targeted Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas HER2 Targeted Therapy Market Size Market Share by Type (2016-2021)
Table 23. Americas HER2 Targeted Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas HER2 Targeted Therapy Market Size Market Share by Application (2016-2021)
Table 25. APAC HER2 Targeted Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC HER2 Targeted Therapy Market Size Market Share by Region (2016-2021)
Table 27. APAC HER2 Targeted Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC HER2 Targeted Therapy Market Size Market Share by Type (2016-2021)
Table 29. APAC HER2 Targeted Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC HER2 Targeted Therapy Market Size Market Share by Application (2016-2021)
Table 31. Europe HER2 Targeted Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe HER2 Targeted Therapy Market Size Market Share by Country (2016-2021)
Table 33. Europe HER2 Targeted Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe HER2 Targeted Therapy Market Size Market Share by Type (2016-2021)
Table 35. Europe HER2 Targeted Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe HER2 Targeted Therapy Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa HER2 Targeted Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa HER2 Targeted Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa HER2 Targeted Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of HER2 Targeted Therapy
Table 44. Key Application and Potential Industries of HER2 Targeted Therapy
Table 45. Key Challenges of HER2 Targeted Therapy
Table 46. Key Trends of HER2 Targeted Therapy
Table 47. Global HER2 Targeted Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global HER2 Targeted Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global HER2 Targeted Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global HER2 Targeted Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global HER2 Targeted Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global HER2 Targeted Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 53. GlaxoSmithKline Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 54. GlaxoSmithKline HER2 Targeted Therapy Product Offered
Table 55. GlaxoSmithKline HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. GlaxoSmithKline Main Business
Table 57. GlaxoSmithKline Latest Developments
Table 58. Bayer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 59. Bayer HER2 Targeted Therapy Product Offered
Table 60. Bayer Main Business
Table 61. Bayer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Bayer Latest Developments
Table 63. Abbott Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 64. Abbott HER2 Targeted Therapy Product Offered
Table 65. Abbott Main Business
Table 66. Abbott HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Abbott Latest Developments
Table 68. AbbVie Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 69. AbbVie HER2 Targeted Therapy Product Offered
Table 70. AbbVie Main Business
Table 71. AbbVie HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. AbbVie Latest Developments
Table 73. Pfizer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 74. Pfizer HER2 Targeted Therapy Product Offered
Table 75. Pfizer Main Business
Table 76. Pfizer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Pfizer Latest Developments
Table 78. Sanofi Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 79. Sanofi HER2 Targeted Therapy Product Offered
Table 80. Sanofi Main Business
Table 81. Sanofi HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Sanofi Latest Developments
Table 83. Agilent Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 84. Agilent HER2 Targeted Therapy Product Offered
Table 85. Agilent Main Business
Table 86. Agilent HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Agilent Latest Developments
Table 88. Glenmark Pharmaceuticals Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 89. Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered
Table 90. Glenmark Pharmaceuticals Main Business
Table 91. Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Glenmark Pharmaceuticals Latest Developments
Table 93. Merck Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 94. Merck HER2 Targeted Therapy Product Offered
Table 95. Merck Main Business
Table 96. Merck HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Merck Latest Developments
Table 98. Roche Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 99. Roche HER2 Targeted Therapy Product Offered
Table 100. Roche Main Business
Table 101. Roche HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Roche Latest Developments
Table 103. Novartis Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 104. Novartis HER2 Targeted Therapy Product Offered
Table 105. Novartis HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Astra Zeneca Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 109. Astra Zeneca HER2 Targeted Therapy Product Offered
Table 110. Astra Zeneca Main Business
Table 111. Astra Zeneca HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. Astra Zeneca Latest Developments
Table 113. Daiichi Sankyo Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 114. Daiichi Sankyo HER2 Targeted Therapy Product Offered
Table 115. Daiichi Sankyo Main Business
Table 116. Daiichi Sankyo HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. Daiichi Sankyo Latest Developments
List of Figures
Figure 1. HER2 Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HER2 Targeted Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global HER2 Targeted Therapy Market Size Market Share by Type in 2020
Figure 7. HER2 Targeted Therapy in Breast Cancer
Figure 8. Global HER2 Targeted Therapy Market: Breast Cancer (2016-2021) & ($ Millions)
Figure 9. HER2 Targeted Therapy in Stomach Cancer
Figure 10. Global HER2 Targeted Therapy Market: Stomach Cancer (2016-2021) & ($ Millions)
Figure 11. HER2 Targeted Therapy in Head and Neck Cancer
Figure 12. Global HER2 Targeted Therapy Market: Head and Neck Cancer (2016-2021) & ($ Millions)
Figure 13. HER2 Targeted Therapy in Lung Cancer
Figure 14. Global HER2 Targeted Therapy Market: Lung Cancer (2016-2021) & ($ Millions)
Figure 15. HER2 Targeted Therapy in Ovarian Cancer
Figure 16. Global HER2 Targeted Therapy Market: Ovarian Cancer (2016-2021) & ($ Millions)
Figure 17. HER2 Targeted Therapy in Others
Figure 18. Global HER2 Targeted Therapy Market: Others (2016-2021) & ($ Millions)
Figure 19. Global HER2 Targeted Therapy Market Size Market Share by Application in 2020
Figure 20. Global HER2 Targeted Therapy Revenue Market Share by Player in 2020
Figure 21. Global HER2 Targeted Therapy Market Size Market Share by Regions (2016-2021)
Figure 22. Americas HER2 Targeted Therapy Market Size 2016-2021 ($ Millions)
Figure 23. APAC HER2 Targeted Therapy Market Size 2016-2021 ($ Millions)
Figure 24. Europe HER2 Targeted Therapy Market Size 2016-2021 ($ Millions)
Figure 25. Middle East & Africa HER2 Targeted Therapy Market Size 2016-2021 ($ Millions)
Figure 26. Americas HER2 Targeted Therapy Market Size Market Share by Country in 2020
Figure 27. Americas HER2 Targeted Therapy Market Size Market Share by Type in 2020
Figure 28. Americas HER2 Targeted Therapy Market Size Market Share by Application in 2020
Figure 29. United States HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 30. Canada HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 31. Mexico HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 32. APAC HER2 Targeted Therapy Market Size Market Share by Regions in 2020
Figure 33. APAC HER2 Targeted Therapy Market Size Market Share by Type in 2020
Figure 34. APAC HER2 Targeted Therapy Market Size Market Share by Application in 2020
Figure 35. China HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 36. Japan HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. Korea HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 38. Southeast Asia HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 39. India HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 40. Australia HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 41. Europe HER2 Targeted Therapy Market Size Market Share by Country in 2020
Figure 42. Europe HER2 Targeted Therapy Market Size Market Share by Type in 2020
Figure 43. Europe HER2 Targeted Therapy Market Size Market Share by Application in 2020
Figure 44. Germany HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. France HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 46. UK HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 47. Italy HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 48. Russia HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 49. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region in 2020
Figure 50. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type in 2020
Figure 51. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application in 2020
Figure 52. Egypt HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 53. South Africa HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 54. Israel HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 55. Turkey HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 56. GCC Country HER2 Targeted Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 57. Americas HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 58. APAC HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 59. Europe HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Middle East & Africa HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 61. United States HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Canada HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 63. Mexico HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 64. Brazil HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 65. China HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 66. Japan HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 67. Korea HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 68. Southeast Asia HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 69. India HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 70. Australia HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 71. Germany HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 72. France HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 73. UK HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 74. Italy HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 75. Russia HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 76. Spain HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 77. Egypt HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 78. South Africa HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 79. Israel HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 80. Turkey HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
Figure 81. GCC Country HER2 Targeted Therapy Market Size 2021-2026 ($ Millions)
